These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8866142)

  • 1. Comparison of two methods to detect P-glycoprotein in patients with chronic lymphocytic leukaemia.
    Chin-Yee I; Alshammari S; Anderson L; Kadri M; Keeney M
    Clin Lab Haematol; 1996 Jun; 18(2):99-104. PubMed ID: 8866142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Common expression of the multidrug resistance marker P-glycoprotein in B-cell chronic lymphocytic leukaemia and correlation with in vitro drug resistance.
    Sparrow RL; Hall FJ; Siregar H; Van der Weyden MB
    Leuk Res; 1993 Nov; 17(11):941-7. PubMed ID: 7901453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality control of multidrug resistance assays in adult acute leukemia: correlation between assays for P-glycoprotein expression and activity.
    Broxterman HJ; Sonneveld P; Feller N; Ossenkoppele GJ; Währer DC; Eekman CA; Schoester M; Lankelma J; Pinedo HM; Löwenberg B; Schuurhuis GJ
    Blood; 1996 Jun; 87(11):4809-16. PubMed ID: 8639853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do P-glycoprotein and major vault protein (MVP/LRP) expression correlate with in vitro daunorubicin resistance in acute myeloid leukemia?
    Broxterman HJ; Sonneveld P; Pieters R; Lankelma J; Eekman CA; Loonen AH; Schoester M; Ossenkoppele GJ; Löwenberg B; Pinedo HM; Schuurhuis GJ
    Leukemia; 1999 Feb; 13(2):258-65. PubMed ID: 10025900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P-glycoprotein inhibitors modulate accumulation and efflux of xenobiotics in extra and intracellular Toxoplasma gondii.
    Sauvage V; Aubert D; Bonhomme A; Pinon JM; Millot JM
    Mol Biochem Parasitol; 2004 Mar; 134(1):89-95. PubMed ID: 14747146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P-glycoprotein (PGP) and lung resistance-related protein (LRP) expression and function in leukaemic blast cells.
    Michieli M; Damiani D; Ermacora A; Raspadori D; Michelutti A; Grimaz S; Fanin R; Russo D; Lauria F; Masolini P; Baccarani M
    Br J Haematol; 1997 Feb; 96(2):356-65. PubMed ID: 9029025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison between anthracyclines and rhodamine-123 accumulation in chronic lymphoid leukemia: effect of cyclosporin A and verapamil.
    Maia RC; Vasconcelos FC; Harab RC; Coelho AM; Dobbin JA; Rumjanek VM
    Tumour Biol; 1998; 19(1):41-51. PubMed ID: 9422081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reproducible flow cytometric methodology for measuring multidrug resistance in leukaemic blasts.
    Pallis M; Turzanski J; Langabeer S; Russell NH
    Adv Exp Med Biol; 1999; 457():77-88. PubMed ID: 10500783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemomodulation of drugs involved in multidrug resistance in chronic lymphatic leukemia of the B-cell type.
    Reichle A; Diddens H; Altmayr F; Rastetter J; Andreesen R
    Cancer Chemother Pharmacol; 1994; 34(4):307-16. PubMed ID: 7913420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of a single point flow cytometric assay for determining P-glycoprotein activity in multidrug resistant cell lines.
    Chin-Yee I; Crowther MA; Keeney M; Wright L; Daly S
    Clin Lab Haematol; 1994 Sep; 16(3):261-72. PubMed ID: 7828413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical application of a rapid, functional assay for multidrug resistance based on accumulation of the fluorescent dye, fluo-3.
    Wall DM; Sparrow R; Hu XF; Nadalin G; Zalcberg JR; Marschner IC; Van der Weyden M; Parkin JD
    Eur J Cancer; 1993; 29A(7):1024-7. PubMed ID: 8098947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect on cell kill of addition of multidrug resistance modifiers cyclosporin A and PSC 833 to cytotoxic agents in chronic lymphocytic leukaemia.
    Grey MR; Burgess R; Fisher A; Yin JA
    Leuk Res; 1999 Jan; 23(1):29-35. PubMed ID: 9933132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liposome-encapsulated daunorubicin for PGP-related multidrug resistance.
    Michieli M; Damiani D; Ermacora A; Masolini P; Michelutti A; Michelutti T; Russo D; Pea F; Baccarani M
    Br J Haematol; 1999 Jul; 106(1):92-9. PubMed ID: 10444168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro drug resistance in acute myeloid and chronic B-lymphocytic leukaemic blasts and in normal blood and marrow populations.
    Baines P; Limaye M; Hoy T; Padua RA; Whittaker J; al-Sabah A; Burnett A
    Leuk Res; 1994 Sep; 18(9):683-91. PubMed ID: 7934144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of P-glycoprotein in cell lines and leukemic blasts: failure of select monoclonal antibodies to detect clinically significant Pgp levels in primary cells.
    Taylor BJ; Olson DP; Ivy SP
    Leuk Res; 2001 Dec; 25(12):1127-35. PubMed ID: 11684287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous measurement of cellular P-glycoprotein content and function by multiparametric flow-cytometry.
    Müller MR; Lennartz K; Baack B; Heim MM; Seeber S; Scheulen ME
    Int J Clin Pharmacol Ther; 2000 Apr; 38(4):180-6. PubMed ID: 10783827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P-glycoprotein (PGP), lung resistance-related protein (LRP) and multidrug resistance-associated protein (MRP) expression in acute promyelocytic leukaemia.
    Michieli M; Damiani D; Ermacora A; Geromin A; Michelutti A; Masolini P; Baccarani M
    Br J Haematol; 2000 Mar; 108(4):703-9. PubMed ID: 10792272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of P-glycoprotein expression by immunocytochemistry and flow cytometry using two different monoclonal antibodies coupled with functional efflux analysis in 34 patients with acute myeloid leukemia.
    Poulain S; Lepelley P; Cambier N; Cosson A; Fenaux P; Wattel E
    Adv Exp Med Biol; 1999; 457():57-63. PubMed ID: 10500780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of human peripheral blood T cells does not lead to increased P-glycoprotein expression.
    Mu XY; Gosland MP; Bartik MM; Schimmelpfennig J; Kay NE
    J Clin Immunol; 1999 Jul; 19(4):239-46. PubMed ID: 10471978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect on cell kill of addition of multidrug resistance modifiers cyclosporin A and PSC 833 to cytotoxic agents in acute myeloid leukaemia.
    Grey M; Borg AG; Wood P; Burgess R; Fisher A; Yin JA
    Leuk Res; 1997 Sep; 21(9):867-74. PubMed ID: 9393602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.